Nonthrombogenic, Antiseptic Nitric Oxide Releasing Catheters
非血栓形成、抗菌一氧化氮释放导管
基本信息
- 批准号:8311942
- 负责人:
- 金额:$ 19.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-14
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdhesionsAnimal ModelAnti-Bacterial AgentsBiocompatibleBlood PlateletsBlood VesselsCaringCathetersChemicalsChronicClinical TrialsClinical assessmentsCoagulation ProcessCollaborationsConsultationsConsumptionCritical IllnessDevelopmentDevicesDimethylpolysiloxanesDoseEndotheliumEngineeringEnsureEvaluationExcisionExhibitsExtracorporeal CirculationGamma RaysGoalsHealthHospitalsHumanImplantInfectionLaboratoriesLengthLicensingLiquid substanceLocal Anti-Infective AgentsLocationManufacturer NameMeasuresMethodsMichiganMicrobial BiofilmsModelingNitric OxideNitric Oxide DonorsOryctolagus cuniculusPatientsPerformancePhasePolymer ChemistryPolymersPolyurethanesPreparationPreventionProceduresProductionResearchRiskSafetySheepSilicone ElastomersSmall Business Innovation Research GrantSolutionsSurfaceTechnologyTestingThrombosisThrombusTimeToxic effectUnithiolUniversitiesVinyl ChlorideWorkbacterial resistancebactericidebench to bedsidebiomaterial compatibilitycommercializationcrosslinkdiazeniumdiolateimplantationimprovedin vivomanufacturing scale-upnew technologynovelpaymentpreventprototyperesearch clinical testingscale upsensor
项目摘要
DESCRIPTION (provided by applicant): This project will focus on the preparation and evaluation of nonthrombogenic, antibacterial nitric oxide (NO) releasing catheters. Phase 1 of this SBIR will: 1) develop unique NO secreting catheters (14-20 gauge); 2) test them in rabbit and sheep models to evaluate thrombogenicity and bacterial adherence; Phase 2 will scale up manufacturing and evaluate toxicity in preparation for human trials. The rationale for this research is to mimic the function of the endothelium. Low levels of NO released by the normal endothelium inhibit platelet adhesion and activation, thus preventing thrombus formation. Further, it has been shown that NO at low doses exhibits significant bactericidal activity. Hence, the preparation of catheters that secrete NO will solve two longstanding problems in the care of critically ill patients. The basic NO release polymer technology that employs novel diazeniumdiolate type NO donors has been developed in laboratories at the University of Michigan (U of M) over the past 10 years. Successful applications of this technology have already included the development of anti-platelet coatings for extracorporeal circulation devices and the preparation more biocompatible implantable chemical sensors with improved analytical performance. Via collaboration with the research team at the U of M that has been working on this technology, MC3 now intends to develop and test catheters that release NO at controlled rates in order to prevent thrombosis and infection, two major problems associated with the use of catheters.
PUBLIC HEALTH RELEVANCE: Clotting and infection is a major problem in intravascular (IV) catheters. Normal blood vessels secrete a chemical called nitric oxide which prevents these problems. This research will develop 14-20 gauge catheters which secrete nitric oxide, decreasing the risk of clotting and infection.
描述(由申请人提供):该项目将重点关注非血栓形成、抗菌一氧化氮(NO)释放导管的制备和评估。该 SBIR 第一阶段将: 1) 开发独特的 NO 分泌导管(14-20 规格); 2)在兔和绵羊模型中进行测试,以评估血栓形成性和细菌粘附性;第二阶段将扩大生产规模并评估毒性,为人体试验做准备。这项研究的基本原理是模仿内皮的功能。正常内皮释放的低水平NO抑制血小板粘附和活化,从而防止血栓形成。此外,已经表明低剂量的NO表现出显着的杀菌活性。因此,制备分泌NO的导管将解决重症患者护理中长期存在的两个问题。过去 10 年,密歇根大学 (U of M) 的实验室开发了采用新型二氮烯二醇型 NO 供体的基本 NO 释放聚合物技术。该技术的成功应用已经包括开发用于体外循环装置的抗血小板涂层以及制备具有更高分析性能的更具生物相容性的植入式化学传感器。通过与密歇根大学研究团队合作,MC3 现在打算开发和测试以受控速率释放 NO 的导管,以防止血栓形成和感染,这是与使用导管相关的两个主要问题。
公共卫生相关性:凝血和感染是血管内 (IV) 导管的主要问题。正常血管会分泌一种叫做一氧化氮的化学物质,可以预防这些问题。这项研究将开发 14-20 号导管,它可以分泌一氧化氮,降低凝血和感染的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott I Merz其他文献
Scott I Merz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott I Merz', 18)}}的其他基金
Pediatric ECMO Oxygenator with Integrated Monitoring
带集成监控功能的儿科 ECMO 氧合机
- 批准号:
10320808 - 财政年份:2020
- 资助金额:
$ 19.56万 - 项目类别:
Pediatric ECMO Oxygenator with Integrated Monitoring
带集成监控功能的儿科 ECMO 氧合器
- 批准号:
10462756 - 财政年份:2020
- 资助金额:
$ 19.56万 - 项目类别:
Nonthrombogenic, Antiseptic Nitric Oxide Releasing Catheters
非血栓形成、抗菌一氧化氮释放导管
- 批准号:
8902256 - 财政年份:2012
- 资助金额:
$ 19.56万 - 项目类别:
Nonthrombogenic, Antiseptic Nitric Oxide Releasing Catheters
非血栓形成、抗菌一氧化氮释放导管
- 批准号:
8778830 - 财政年份:2012
- 资助金额:
$ 19.56万 - 项目类别:
Novel, Long-Term Percutaneous Access Device for Chronic Therapy
用于慢性治疗的新型长期经皮接入装置
- 批准号:
8726459 - 财政年份:2011
- 资助金额:
$ 19.56万 - 项目类别:
Novel, Long-Term Percutaneous Access Device for Chronic Therapy
用于慢性治疗的新型长期经皮接入装置
- 批准号:
8591332 - 财政年份:2011
- 资助金额:
$ 19.56万 - 项目类别:
相似国自然基金
基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
- 批准号:82305302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组胺通过调控Th1/Th2平衡促进宫腔粘连的机制研究
- 批准号:82360298
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
宫腔粘连子宫内膜NK细胞异常破坏间质稳态致内膜纤维化的机制研究
- 批准号:82371641
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Staphylococcus aureus SasD in Lung
金黄色葡萄球菌 SasD 在肺中的作用
- 批准号:
10748089 - 财政年份:2023
- 资助金额:
$ 19.56万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 19.56万 - 项目类别:
Novel Biofilm Paradigm Explaining Clinical Implant-Associated Illness.
解释临床植入相关疾病的新型生物膜范式。
- 批准号:
10515767 - 财政年份:2022
- 资助金额:
$ 19.56万 - 项目类别:
Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS)
新型婴幼儿抗逆转录病毒治疗递送平台:口服一次性试纸条(ODS)
- 批准号:
10483794 - 财政年份:2022
- 资助金额:
$ 19.56万 - 项目类别: